LINC01134 and hepatocellular carcinoma: has reported that LINC01134 can activate the transcription of AKT1S1 by binding to the promoter of AKT1S1, further activating NF- κB signaling pathway, thereby playing a role in promoting the migration and invasion of HCC cells (10).